Startup entity
regulation is the sole category represented across all 1 tracked stories. Food and Drug Administration is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The 8 average consequence score is above the beat benchmark of 6.6 in the same window.
Last mentioned: Jul 21, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
regulation is the sole category represented across all 1 tracked stories. Food and Drug Administration is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The 8 average consequence score is above the beat benchmark of 6.6 in the same window. Source depth averages 2 original sources per story, versus 2.3 across the same-window beat baseline. Moderna Inc. appears in 1 tracked Startup story from March 16, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 40 Startup stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Moderna Inc.. Shared-story counts are live from our verified record — not editorial picks.
Application Refusal
FDA senior regulator Vinay Prasad issues a formal refusal to review the flu vaccine application.
Grants Rescinded
White House rescinds hundreds of millions in mRNA research grants by year-end.
Workaround Supported
Regulators appear to support Moderna's plan to use data from a smaller trial to address dosage concerns.
Collaboration Begins
FDA begins working closely with Moderna on its flu vaccine trial design.
Moderna faces a significant regulatory setback as the FDA refuses to review its new flu vaccine, citing trial design flaws despite previous guidance. This shift reflects a broader, politically charged environment that threatens to destabilize the venture-backed biotech ecosystem.
Moderna Inc. is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
